NOD2 attenuates osteoarthritis via reprogramming the activation of synovial macrophages

Changchuan Li1, Zhuji Ouyang1, Yuhsi Huang1

  • 1Department of Orthopaedic Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China.

PubMed
Abstract

Insights

NOD2 inhibits macrophage activation and M1 polarization in osteoarthritis (OA) by negatively regulating HMGB1/TLR4 signaling. This finding suggests NOD2 as a potential therapeutic target for OA prevention and treatment.

Area of Science:

  • Immunology
  • Pathology
  • Molecular Biology

Background:

  • Synovial inflammation is an early pathological event in osteoarthritis (OA).
  • Macrophage activation and M1 polarization are key drivers of synovial inflammation in OA.
  • Mechanisms regulating macrophage activation and polarization in OA are not fully understood.

Purpose of the Study:

  • To investigate the role of NOD2 in modulating macrophage activation and polarization.
  • To explore the relationship between NOD2 and the HMGB1/TLR4 signaling pathway in OA pathogenesis.
  • To assess the therapeutic potential of NOD2 in OA.

Main Methods:

  • Examined NOD2 expression in human osteoarthritic synovium.
  • Utilized in vitro knockdown and overexpression models to study NOD2's effect on macrophage activation and polarization.
  • Evaluated the paracrine effects of macrophages on fibroblast-like synoviocytes (FLS) and chondrocytes.
  • Assessed the in vivo efficacy of NOD2 in a collagenase-induced mouse model of OA.

Main Results:

  • NOD2 expression was upregulated in osteoarthritic synovium.
  • NOD2 acted as a negative regulator of the HMGB1/TLR4 signaling pathway in vitro.
  • NOD2 overexpression reduced the inflammatory paracrine effects of macrophages on FLS and chondrocytes.
  • In vivo, NOD2 overexpression ameliorated OA in mice.

Conclusions:

  • NOD2 plays an inhibitory role in the activation and M1 polarization of synovial macrophages.
  • This study offers novel insights into the innate immune system's involvement in OA.
  • NOD2 represents a promising therapeutic target for OA prevention and treatment.